insights_auto
Why is BIAF down 7.19%?
Dive Deeperchevron_right
BIAF:NASDAQ
bioAffinity Technologies Inc
$7.94
arrow_downward
-7.19%(-0.62) 1D
$7.57
arrow_downward
-4.64% (-0.37)bedtimeAfter hours
Closed: Sep 23, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIAF...
Open
$8.40
High
$8.55
Low
$7.82
Mkt. cap
9.26M
Avg. vol.
12.20M
Volume
207.88K
52-wk high
$109.35
52-wk low
$4.56
EPS
-$103.35
Beta
-1.11
Shares outstanding
1.17M
No. of employees
57
Open
$8.40
High
$8.55
Low
$7.82
Mkt. cap
9.26M
Avg. vol.
12.20M
Volume
207.88K
52-wk high
$109.35
52-wk low
$4.56
EPS
-$103.35
Beta
-1.11
Shares outstanding
1.17M
No. of employees
57
News stories
From web sources and news partners
TipRanks
·
1 day ago
bioAffinity to Highlight CyPath Lung at NAVREF 2026
Investing.com Canada
·
1 day ago
Form 8K bioAffinity Technologies Inc For: 22 September By Investing.com
Stock Titan
·
1 day ago
A 2,000-patient study is evaluating a lung cancer test using at-home samples.
About bioAffinity Technologies Inc
CEO-
Employees57
Founded2014
HeadquartersSan Antonio, Texas, United States
SectorBiotechnology
Website-